Home
Kevin D. Freeman, Director: Galectin Therapeutics GALT Buy · Filed 24/10/17
Trade details
- Type
- Insider buy
- Amount
- $3,432
- Shares · price
- 1,300 sh · $2.64 a share
- Held after
- 34,769 sh
- Person
- Kevin D. FreemanDirector
- Trade date
- 24/10/17
- Filed
- 24/10/17
- Days to filing
- 0 days
First buy since 2023
- Insiders buying this week
- 2 insiders
- Holding change
- +3.9%
Galectin Therapeutics trades, last 26 weeks
What else happened in Galectin Therapeutics around then
Filed or reported within 30 days of the trade day · 24/09/17~24/11/16Kevin D. Freeman's recent trades
- Kevin D. Freeman
BuyGalectin Therapeutics
BuyGalectin Therapeutics
GALT
$19.5K
5,500 sh
$19.5K
Filed 25/12/23
Traded 25/12/23
- Kevin D. Freeman
Buy10b5-1 planGalectin Therapeutics
Buy10b5-1 planGalectin Therapeutics
GALT
$19.5K
5,500 sh
$19.5K
Filed 25/12/23
Traded 25/12/23
- Kevin D. Freeman
Buy10b5-1 planGalectin Therapeutics
Buy10b5-1 planGalectin Therapeutics
GALT
$19.5K
5,500 sh
$19.5K
Filed 25/12/23
Traded 25/12/23
- Kevin D. Freeman
BuyGalectin Therapeutics
BuyGalectin Therapeutics
GALT
$14.5K
5,000 sh
$14.5K
Filed 25/07/18
Traded 25/07/17
- Kevin D. Freeman
BuyGalectin Therapeutics
BuyGalectin Therapeutics
GALT
$8,100
10,000 sh
$8,100
Filed 24/12/26
Traded 24/12/24